Miles 33 Group Ltd (“Miles 33″), a leading supplier of digital publishing software, has completed a secondary management buyout funded by Ethos Partners and Santander. This deal provides exciting new opportunities for Miles 33, and FirstCapital is delighted to have advised the company’s shareholders on the deal.
Bracknell-based Miles 33 is a global provider of best-in-class editorial and advertising management software to the newspaper and publishing sectors, as well as wider corporate marketing automation software products. The business was established in 1976 and over the last 10 years has completed and integrated seven bolt-on acquisitions. The secondary buyout will allow Miles 33 to continue helping publishers with digital transformation, driving down costs and reducing inefficiencies in the industry, and enabling the company to take advantage of growth opportunities, particularly in the US.
Mike Moore, CEO, Miles 33, said: “It has been a pleasure working with FirstCapital. They added value from day one; doing a deep dive on the business, challenging us constructively on our thinking and positioning, and working with us to articulate our strategy and to put in place solid preparation for the process. Throughout the transaction they have provided great commitment and support to me and my team, all the way through to the close. I have particularly appreciated their ability to listen to all sides, maintain focus on key objectives and ensure excellent communication and alignment between all the stakeholders. As a result, we have completed a win-win deal that delivers for everyone, which is an excellent outcome.”
Hazel Moore, Chairman of FirstCapital, said: “Miles 33 is a respected industry name with a proven track record. We are delighted to have supported the company and the management team to complete this buy-out. With new backing for the next phase of growth, as well as market-leading products and considerable industry expertise, we’re excited for Mike and the team and are looking forward to their continued success.”